A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study)

BACKGROUND: There is a concern that topical tacrolimus and pimecrolimus, indicated for second-line treatment of atopic dermatitis, may increase the risk of lymphoma and skin cancer, particularly in children. OBJECTIVE: The aim of this study was to compare incidence rates (IRs) of lymphoma and skin c...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellsague, Jordi, Kuiper, Josephina G, Pottegård, Anton, Anveden Berglind, Ingegärd, Dedman, Daniel, Gutierrez, Lia, Calingaert, Brian, van Herk-Sukel, Myrthe PP, Hallas, Jesper, Sundström, Anders, Gallagher, Arlene M, Kaye, James A, Pardo, Carolina, Rothman, Kenneth J, Perez-Gutthann, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856050/
https://www.ncbi.nlm.nih.gov/pubmed/29559812
http://dx.doi.org/10.2147/CLEP.S146442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856050/
https://www.ncbi.nlm.nih.gov/pubmed/29559812
http://dx.doi.org/10.2147/CLEP.S146442

Ejemplares similares